In the context of cancer, aberrant PLK4 expression compromises mitotic fidelity and centrosome homeostasis, exacerbates replication-associated DNA damage, and impairs the DDR efficiency, thereby promoting chromosomal instability and tumor progression [61]. This evidence concerns the gene PLK4 and cancer.